Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer

Authors :: Mario Mairhofer
Susanne Kimeswenger
Riad Ghanem
Maria Pammer
Lea Kausche
Anna Habringer
Helmut J F Salzer
Soyoung Lee
Isabella Rauscher
Clemens A. Schmitt
Sabine Kaltenbrunner
Bernd Lamprecht
Christian Paar
Wolfram Hoetzenecker
Stefan Doppler
Maike Stegemann
Katharina Klein
Source :: Cancer Cell
Publication Year :: 2021
Abstract: SARS-CoV-2 vaccines are effective in preventing COVID-19. Patients with cancer are at high risk for severe COVID-19 and are appropriately prioritized for vaccination. Several studies in this issue of Cancer Cell add to our knowledge of the heterogeneity of immune responses to vaccination among patients with cancer and identify important areas for future research.

Tools